Reaction
Rectal Discharge reporting signals
As of the last recalculation, Rectal Discharge appears in 3,662 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ORLISTAT (PRR 1,588.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Orlistat | 2,433 | 1,588.6 | 1,754.2 |
| Vedolizumab | 166 | 11.4 | 11.4 |
| Quinine | 13 | 8.6 | 8.7 |
| Teduglutide | 17 | 7.2 | 7.2 |
| Mesalamine | 64 | 6.6 | 6.6 |
| Psyllium Husk | 9 | 5.2 | 5.2 |
| Hyoscyamine Sulfate | 8 | 5.0 | 5.0 |
| Infliximab-Dyyb | 24 | 4.7 | 4.7 |
| Regorafenib | 9 | 4.4 | 4.4 |
| Peginterferon Alfa-2A | 17 | 1.8 | 1.8 |
| Relugolix | 4 | 1.0 | 1.0 |